Latin America, emerging markets for Korean drug manufacturers

Published: 2010-02-17 06:56:00

Updated: 2010-02-17 06:56:00

Intensifying generic competition and regulatory developments in Latin America are making these markets more attractive for Korean pharmaceutical companies, according to a local report.

Korea Trade Investment Promotion Agency (KOTRA) has published a report on the outlook for pharmaceuticals in ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK